Panel Discussion: Reflecting on the Past Year- Discussing Current Radiopharmaceutical Trends & Assessing Our Progress

Time: 8:30 am
day: Conference Day One


  • Exploring PSMA updates and predictions for the future market of prostate cancer drugs
  • Pricing and reimbursement considerations in a competitive market
  • Discussing key future commercial challenges and opportunities for the field from advances in manufacturing to competitive demand and selection of radioisotopes, with emphasis on actinium-225, lead-212, copper-64